Reasons associated with treatment non-adherence in schizophrenia in a Pakistan cohort

被引:18
作者
Ahmad, Irshad [1 ]
Khalily, Muhammad Tahir [1 ]
Hallahan, Brian [2 ]
机构
[1] Int Islamic Univ, Dept Psychol, Islamabad, Pakistan
[2] Natl Univ Ireland, Dept Psychiat, Galway, Ireland
关键词
Pharmacotherapy; Psychotic relapse; Schizophrenia; Treatment non-adherence; MENTAL-HEALTH NURSES; ANTIPSYCHOTIC MEDICATION; 1ST EPISODE; ADHERENCE; NONCOMPLIANCE; INTERVENTION; PSYCHOSIS; RELAPSE; FAMILY; PREDICTORS;
D O I
10.1016/j.ajp.2017.07.024
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Treatment: non-adherence in patients with schizophrenia is the most common reason for a relapse of psychosis. In a cohort of participants in Pakistan who suffered a relapse of psychosis, we aimed to identify the principal factors associated with non-adherence, including any culture specific factors that might not be as significant in other jurisdictions. Semi-structured interviews were undertaken at four psychiatric hospitals in the Peshawar region in Pakistan with 55 participants (44 male and 11 female) diagnosed with schizophrenia, who had suffered a relapse of psychosis subsequent to treatment non-adherence. The five principal documented reasons for treatment non-adherence were: 1) alternative treatment pathway chosen with a traditional faith healers (n = 53, 96.4%), 2) lack of insight (n = 36, 65.5%), 3) poor economic status (n = 33, 60.0%), 4) adverse effects of medications (n = 33, 60.0%) and 5) utilising psycho-active substances as an alternative to psychotropic medications (n = 27, 41.1%). A number of identified factors associated with a relapse of psychosis are potentially modifiable including the provision of a range of pharmacological options including second generation antipsychotic agents, long acting injectable antipsychotics and psycho-therapeutic interventions including psychoeducation. These interventions should prove cost effective and be associated with reduced relapse rates of psychosis.
引用
收藏
页码:39 / 43
页数:5
相关论文
共 47 条
  • [1] Factors associated with psychotic relapse in patients with schizophrenia in a Pakistani cohort
    Ahmad, Irshad
    Khalily, Muhammad Tahir
    Hallahan, Brian
    Shah, Inayat
    [J]. INTERNATIONAL JOURNAL OF MENTAL HEALTH NURSING, 2017, 26 (04) : 384 - 390
  • [2] Amr M, 2013, EUR PSYCHIAT, V28
  • [3] [Anonymous], 2013, IBM SPSS STAT WINDOW
  • [4] The burden of schizophrenia on caregivers - A review
    Awad, A. George
    Voruganti, Lakshmi N. P.
    [J]. PHARMACOECONOMICS, 2008, 26 (02) : 149 - 162
  • [5] Interventions to improve adherence to antipsychotic medication in patients with schizophrenia-A review of the past decade
    Barkhof, E.
    Meijer, C. J.
    de Sonneville, L. M. J.
    Linszen, D. H.
    de Haan, L.
    [J]. EUROPEAN PSYCHIATRY, 2012, 27 (01) : 9 - 18
  • [6] Evolving role of mental health nurses in the physical health care of people with serious mental health illness
    Bradshaw, Tim
    Pedley, Rebecca
    [J]. INTERNATIONAL JOURNAL OF MENTAL HEALTH NURSING, 2012, 21 (03) : 266 - 273
  • [7] Chandra Ivatury Sarath, 2014, Indian J Psychol Med, V36, P294, DOI 10.4103/0253-7176.135383
  • [8] World Federation of Societies of Biological Psychiatry (WFSBP) -: Guidelines for biological treatment of schizophrenia, part 1:: Acute treatment of schizophrenia
    Falkai, P
    Wobrock, T
    Lieberman, J
    Glenthoj, B
    Gattaz, WF
    Möller, HJ
    [J]. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2005, 6 (03) : 132 - 191
  • [9] Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies
    Haddad, Peter M.
    Brain, Cecilia
    Scott, Jan
    [J]. PATIENT-RELATED OUTCOME MEASURES, 2014, 5 : 43 - 62
  • [10] Rethinking schizophrenia
    Insel, Thomas R.
    [J]. NATURE, 2010, 468 (7321) : 187 - 193